These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 8968360

  • 1. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
    Yamada T, Niinuma K, Lemaire M, Terasaki T, Sugiyama Y.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
    [Abstract] [Full Text] [Related]

  • 2. Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro.
    Yamada T, Niinuma K, Lemaire M, Terasaki T, Sugiyama Y.
    Drug Metab Dispos; 1997 May; 25(5):536-43. PubMed ID: 9152591
    [Abstract] [Full Text] [Related]

  • 3. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).
    Ishizuka H, Konno K, Naganuma H, Sasahara K, Kawahara Y, Niinuma K, Suzuki H, Sugiyama Y.
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317
    [Abstract] [Full Text] [Related]

  • 4. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.
    Yamazaki M, Akiyama S, Ni'inuma K, Nishigaki R, Sugiyama Y.
    Drug Metab Dispos; 1997 Oct; 25(10):1123-9. PubMed ID: 9321514
    [Abstract] [Full Text] [Related]

  • 5. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
    Yamazaki M, Kobayashi K, Sugiyama Y.
    Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
    [Abstract] [Full Text] [Related]

  • 6. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
    Sasabe H, Tsuji A, Sugiyama Y.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Species differences in the transport activity for organic anions across the bile canalicular membrane.
    Ishizuka H, Konno K, Shiina T, Naganuma H, Nishimura K, Ito K, Suzuki H, Sugiyama Y.
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1324-30. PubMed ID: 10454510
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
    Han YH, Kato Y, Watanabe Y, Terao K, Asoh Y, Sugiyama Y.
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
    [Abstract] [Full Text] [Related]

  • 17. Impaired biliary excretion and whole body elimination of methylmercury in rats with congenital defect in biliary glutathione excretion.
    Ballatori N, Gatmaitan Z, Truong AT.
    Hepatology; 1995 Nov; 22(5):1469-73. PubMed ID: 7590665
    [Abstract] [Full Text] [Related]

  • 18. Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia.
    Takenaka O, Horie T, Kobayashi K, Suzuki H, Sugiyama Y.
    Pharm Res; 1995 Nov; 12(11):1746-55. PubMed ID: 8592681
    [Abstract] [Full Text] [Related]

  • 19. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
    Takenaka O, Horie T, Suzuki H, Sugiyama Y.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1362-9. PubMed ID: 7562509
    [Abstract] [Full Text] [Related]

  • 20. Hepatic uptake of bromosulfophthalein-glutathione in perfused Eisai hyperbilirubinemic mutant rat liver: a multiple-indicator dilution study.
    Geng W, Schwab AJ, Horie T, Goresky CA, Pang KS.
    J Pharmacol Exp Ther; 1998 Feb; 284(2):480-92. PubMed ID: 9454788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.